These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pharmacological prevention of migraine: to be considered case by case. Prescrire Int; 2006 Oct; 15(85):184-8. PubMed ID: 17128528 [TBL] [Abstract][Full Text] [Related]
23. Sandomigran in the treatment of migrainous patients. Bánki CM; Vigváry L Ther Hung; 1981; 29(4):181-5. PubMed ID: 7188144 [No Abstract] [Full Text] [Related]
26. [Current views on migraine and anti-migraine preparations]. Ignatov IuD; Skoromets AA; Amelin AV Vestn Ross Akad Med Nauk; 2003; (10):13-9. PubMed ID: 14598505 [TBL] [Abstract][Full Text] [Related]
27. A retrospective study to assess the migraine headache remission rate after cessation of pizotifen therapy. Capildeo R; Wimalaratna HS; Bosley E; Shah SN Br J Clin Pract; 1990 Dec; 44(12):622-6. PubMed ID: 2102160 [No Abstract] [Full Text] [Related]
28. Severe weight loss after withdrawal of chronic pizotifen treatment. Jowett NI J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):137. PubMed ID: 9667582 [No Abstract] [Full Text] [Related]
29. Pizotifen once daily in the prophylaxis of migraine: results of a multi-centre general practice study. Crowder D; Maclay WP Curr Med Res Opin; 1984; 9(4):280-5. PubMed ID: 6391831 [TBL] [Abstract][Full Text] [Related]
31. Pizotifen (Sanomigran) in childhood migraine. A double-blind controlled trial. Gillies D; Sills M; Forsythe I Eur Neurol; 1986; 25(1):32-5. PubMed ID: 3510125 [TBL] [Abstract][Full Text] [Related]
32. Double blind placebo controlled trial of pizotifen syrup in the treatment of abdominal migraine. Symon DN; Russell G Arch Dis Child; 1995 Jan; 72(1):48-50. PubMed ID: 7717738 [TBL] [Abstract][Full Text] [Related]
33. [Effect of joint administration of antagonists of serotonin, histamine and acetylcholine on ventilatory disorders in asthma]. Jonderko G; Kwiatek R; Bierowiec J; Górnisiewicz J; Kapela-Lachowicz B; Olak Z Pol Tyg Lek; 1978 Jul; 33(31):1219-21. PubMed ID: 358167 [No Abstract] [Full Text] [Related]
34. Do pizotifen or propranolol reduce the frequency of migraine headache? Barnes N; Millman G Arch Dis Child; 2004 Jul; 89(7):684-5. PubMed ID: 15210509 [No Abstract] [Full Text] [Related]
35. A comparison between placebo, pizotifen and 1-isopropyl-3-hydroxy-5-semicarbazono-6-oxo-2.3.5.6-tetrahydroindol (Divascan) in migraine prophylaxis. Osterman PO Acta Neurol Scand; 1977 Jul; 56(1):17-28. PubMed ID: 327746 [TBL] [Abstract][Full Text] [Related]
36. Long-term administration of pizotifen to migraine patients: effects on oral glucose tolerance tests and on insulin levels. Cerdan A; Acosta M; Jolin T; Spain M Headache; 1975 Jul; 15(2):126-8. PubMed ID: 1150429 [No Abstract] [Full Text] [Related]
38. The use of sumatriptan in the treatment of migraine. Gross M Br J Clin Pract; 1993; 47(4):205-7. PubMed ID: 8260340 [TBL] [Abstract][Full Text] [Related]
39. [Migraine prevention by a calcium channel blocker. Results of a double-blind study of flunarizine vs. pizotifen]. Wörz R; Drillisch C MMW Munch Med Wochenschr; 1983 Jul; 125(32-33):711-14. PubMed ID: 6415411 [No Abstract] [Full Text] [Related]